These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 34721037)
21. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma. Lou X; Li J; Yu D; Wei YQ; Feng S; Sun JJ Cancer Med; 2019 Sep; 8(12):5735-5749. PubMed ID: 31392826 [TBL] [Abstract][Full Text] [Related]
22. Construction of a ceRNA Network and a Prognostic lncRNA Signature associated with Vascular Invasion in Hepatocellular Carcinoma based on Weighted Gene Co-Expression Network Analysis. Tao H; Li J; Liu J; Yuan T; Zhang E; Liang H; Huang Z J Cancer; 2021; 12(13):3754-3768. PubMed ID: 34093785 [No Abstract] [Full Text] [Related]
23. Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights Dong X; Jin C; Chen D; Chen Y; Ye ZQ; Zhang X; Huang X; Zhang W; Gu DN Front Oncol; 2021; 11():737867. PubMed ID: 34604079 [TBL] [Abstract][Full Text] [Related]
24. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
25. The Role of m6A RNA Methylation-Related lncRNAs in the Prognosis and Tumor Immune Microenvironment of Papillary Thyroid Carcinoma. Wang W; Shen C; Zhao Y; Sun B; Qiu X; Yin S; Chen J; Li X Front Cell Dev Biol; 2021; 9():719820. PubMed ID: 35047491 [TBL] [Abstract][Full Text] [Related]
26. Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma. Zhou S; Fang J; Sun Y; Li H Front Genet; 2020; 11():934. PubMed ID: 33193574 [TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature. You X; Yang S; Sui J; Wu W; Liu T; Xu S; Cheng Y; Kong X; Liang G; Yao Y Cancer Manag Res; 2018; 10():4297-4310. PubMed ID: 30349364 [TBL] [Abstract][Full Text] [Related]
28. Establishment and validation of lncRNA-related prognostic signatures in cholangiocarcinoma. Li F; Zhang J; Zhang J; Xue H; Liu L; Yang Z; Dong H; Wang K Genomics; 2023 May; 115(3):110621. PubMed ID: 37068643 [TBL] [Abstract][Full Text] [Related]
29. Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms. Ding Y; Li T; Yan X; Cui M; Wang C; Wang S; Zhang F; Zhang R Mol Genet Genomics; 2021 Mar; 296(2):423-435. PubMed ID: 33507382 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of Long Non-coding RNA-Associated Competing Endogenous RNA Network in Duchenne Muscular Dystrophy. Xu X; Hao Y; Xiong S; He Z Interdiscip Sci; 2020 Dec; 12(4):447-460. PubMed ID: 32876881 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma. Luo Q; Cui M; Deng Q; Liu J Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192 [TBL] [Abstract][Full Text] [Related]
33. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
34. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236 [TBL] [Abstract][Full Text] [Related]
35. Construction and analysis of a lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in oral cancer. Yin J; Zeng X; Ai Z; Yu M; Wu Y; Li S BMC Med Genomics; 2020 Jun; 13(1):84. PubMed ID: 32571304 [TBL] [Abstract][Full Text] [Related]
36. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma. Liu K; Li Z; Ruan D; Wang H; Wang W; Zhang G Front Genet; 2022; 13():890641. PubMed ID: 35860468 [No Abstract] [Full Text] [Related]
37. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models. Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990 [TBL] [Abstract][Full Text] [Related]
38. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs). Xu Y; Chen J; Yang Z; Xu L Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559 [TBL] [Abstract][Full Text] [Related]
39. Identification of DGUOK-AS1 as a Prognostic Factor in Breast Cancer by Bioinformatics Analysis. Li Y; Liang Y; Ma T; Yang Q Front Oncol; 2020; 10():1092. PubMed ID: 32766141 [No Abstract] [Full Text] [Related]
40. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]